balance-study-logo

New clinical research study for Fabry from Protalix

The BALANCE Study is a clinical research study that will compare the safety and efficacy of an investigational medication (a potential new medication) with an approved medication (agalsidase beta, also known as Fabrazyme) in patients with Fabry disease. The investigational medication is a type of medication called “enzyme replacement therapy,” or ERT. The investigational medication … Continue reading “New clinical research study for Fabry from Protalix”

Read More

Subscribe to Our Newsletter